Target intelligence / Profile preview

Short ragweed pollen-specific IgE-mediated immune response

Molecular classification
Other (immune process, not a single molecule or receptor)
01

Overview

The "Short ragweed pollen-specific IgE-mediated immune response" does **not refer to a single molecule or receptor**, but rather describes an **immunological process**. This process involves the production of immunoglobulin E (**IgE**) antibodies that are specific to allergens found in short ragweed (*Ambrosia artemisiifolia*) pollen. When individuals sensitized to these allergens are exposed again, their preformed allergen-specific IgE binds and cross-links on high-affinity FcεRI receptors located on mast cells and basophils[2]. This triggers degranulation of these cells and release of mediators such as histamine, prostaglandins, leukotrienes, and cytokines—leading to immediate allergic symptoms like sneezing, itching, nasal congestion ("hay fever"), or even asthma attacks[2]. The late-phase reaction involves recruitment of additional inflammatory cells including eosinophils and Th2 lymphocytes. Chronic exposure can lead to persistent inflammation characteristic of allergic diseases such as perennial rhinitis or asthma[2]. The level of allergen-specific serum IgE can remain elevated long after exposure ceases due to immunological memory[1]. Therapeutic interventions do not directly target this "response," but rather components within it—such as blocking IgE with monoclonal antibodies like omalizumab; inhibiting mast cell activation; or using allergen immunotherapy which aims at inducing protective antibody responses such as specific IgG4 that block allergen-IgE interactions[1]. Measurement of short ragweed pollen-specific serum IgE serves as a diagnostic biomarker. Because this entry refers broadly to an **immune mechanism** rather than a discrete molecular entity suitable for direct pharmacologic targeting or structural annotation, it should be flagged as incorrect if used where only canonical molecules/receptors/targets are appropriate.

Other names
Ragweed pollen allergy IgE responseAmbrosia artemisiifolia-specific IgE responsePollen-induced allergic immune response (ragweed)
02

Biological functions

Immune responseAllergic inflammationType 2 hypersensitivity reaction
03

Disease associations

InflammationAllergy (allergic rhinitis, hay fever)Asthma exacerbation

Beyond the preview

Go deeper on Short ragweed pollen-specific IgE-mediated immune response.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Short ragweed pollen-specific IgE-mediated immune response.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call